ANI Pharma (ANIP) Tops Q2 EPS by 34c; Boosts FY16 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BE
8. FIX
9. NDAQ
10. TSCO

Go back to ANI Pharma (ANIP) Tops Q2 EPS by 34c; Boosts FY16 Outlook

ANI Pharmaceuticals Reports Record Second Quarter Results and Increases Full-year 2016 Guidance

August 4, 2016 8:30 AM EDT

BAUDETTE, Minn., Aug. 4, 2016 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and six months ended June 30, 2016, and increased its financial guidance for 2016. The Company will host its earnings conference call this morning, August 4, 2016, at 10:30 AM ET. Investors and other interested parties can join the call by dialing (866) 776-8875. The conference ID is 47510730.

Financial Summary

(in thousands, except per share data)

Q2... More